PHS
KURA icon

PFM Health Sciences’s Kura Oncology KURA Stock Holding History

PFM Health Sciences’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,143,917
Closed -$16.1M – 107
2018
Q4 		$16.1M Buy
1,143,917
+40,261
+4% +$533K 0.43% 63
2018
Q3 		$19.3M Buy
1,103,656
+16,533
+2% +$317K 0.28% 92
2018
Q2 		$19.8M Sell
1,087,123
-252,239
-19% -$4.27M 0.31% 91
2018
Q1 		$25.1M Sell
1,339,362
-412,762
-24% -$8.03M 0.51% 63
2017
Q4 		$26.8M Sell
1,752,124
-659,428
-27% -$9.72M 0.64% 55
2017
Q3 		$36.1M Buy
2,411,552
+374,059
+18% +$3.51M 0.71% 49
2017
Q2 		$18.9M Buy
2,037,493
+4,264
+0.2% +$38.8K 0.51% 61
2017
Q1 		$17.9M Buy
2,033,229
+54,800
+3% +$402K 0.45% 70
2016
Q4 		$11.7M Sell
1,978,429
-29,213
-1% -$157K 0.33% 73
2016
Q3 		$12.5M Buy
2,007,642
+336,478
+20% +$1.7M 0.37% 67
2016
Q2 		$4.53M Buy
1,671,164
+129,212
+8% +$402K 0.14% 73
2016
Q1 		$6.25M Buy
1,541,952
+47,783
+3% +$227K 0.19% 75
2015
Q4 		$12.6M Buy
+1,494,169
New +$11.8M 0.38% 53

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

PFM Health Sciences's KURA Position: Q1 2019 in Review

PFM Health Sciences sold out of Kura Oncology (KURA) in Q1 2019, closing a stake of 1,143,917 shares — an estimated $16.1M sold.

PFM Health Sciences first reported a position in KURA in Q4 2015 and held it in 13 quarters. The position peaked at $36.1M in Q3 2017. 104 funds tracked by Wall St. Rank hold KURA as of Q1 2019.

  • PFM Health Sciences reported no remaining Kura Oncology position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 1,143,917 Kura Oncology shares in Q1 2019, an estimated $16.1M.
  • PFM Health Sciences first reported a position in Kura Oncology in Q4 2015 and held it in 13 quarters.
  • PFM Health Sciences's Kura Oncology position peaked at $36.1M in Q3 2017.
  • 104 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.